News
The Supreme Court weighs public safety concerns surrounding ghost guns in recent Second Amendment decision.
It is time we introduce “Humanity’s Best Exam”—a benchmark that strives to capture a model’s capacity to address public ...
The Supreme Court’s recent unanimous decision on FDA’s drug-approval authority is utterly unremarkable.
The Supreme Court validates political control over public health decisions.
Kennedy, a case that concerns how hospitals that treat a large share of low-income patients are paid by the Medicare program.
The Supreme Court preserves preventive services coverage but emboldens the HHS Secretary.
The Supreme Court allows Department of Education layoffs, a federal court upholds a mifepristone ban, and ...
Lawrence O. Gostin discusses the importance of equity and science in the face of threats to global health security.
Scholars consider the antitrust implications of advances in AI-driven algorithmic pricing.
When a project like the rail line has significant environmental impacts, NEPA requires a “detailed statement” that discusses the project’s negative environmental effects and reasonable alternatives.
The Supreme Court runs afoul of its own equal protection doctrine by ignoring explicit classifications.
Scholars and practitioners examine the Court’s most important regulatory decisions of this past term.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results